Epidermal growth factor Archives
VUMC mourns loss of former Dermatology leader King
Feb. 10, 2022—Longtime faculty member Lloyd E. King Jr., MD, PhD, who joined Vanderbilt University Medical Center in 1977 as chief of the Division of Dermatology, died Feb. 8 at Vanderbilt University Hospital after a brief illness.
New target for colorectal cancer
Mar. 17, 2017—Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development.
Probing mutant EGF receptor regulation
Oct. 10, 2013—Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.
VU study identifies new mechanism for cancer development
Jun. 6, 2013—Researchers at Vanderbilt University Medical Center led by a 32-year-old postdoctoral fellow have discovered a new mechanism for the development of cancer that is challenging conventional scientific wisdom.
